Anixa Investor Sues In Chancery Alleging Insider Stock Moves
An Anixa Biosciences Inc. investor is accusing eight current or former directors and top officers of arranging or benefiting from a downward stock option repricing just before a patent announcement in...To view the full article, register now.
Already a subscriber? Click here to view full article